What does Monopar Therapeutics, Inc. do?

Jun 22 2025 06:53 PM IST
share
Share Via
Monopar Therapeutics, Inc. is a clinical stage biopharmaceutical company focused on developing cancer therapeutics, with a market cap of approximately $208.53 million and a recent net profit of -$3 million. The company operates in the Pharmaceuticals & Biotechnology industry and is categorized as a micro-cap firm.
Overview:
Monopar Therapeutics, Inc. is a clinical stage biopharmaceutical company focused on developing therapeutics for cancer patients, operating within the Pharmaceuticals & Biotechnology industry and categorized as a micro-cap company.

Financial Snapshot:
Most recent Net Profit: -3 Million (Quarterly Results - Mar 2025)
Market cap: USD 208.53 Million (Micro Cap)

Key Metrics:
P/E: NA (Loss Making)
Industry P/E: NA
Dividend Yield: 0.00%
Debt Equity: -1.02
Return on Equity: -30.92%
Price to Book: 3.89

Contact Details:
Address: 1000 Skokie Blvd Ste 350, WILMETTE IL: 60091-1146
Tel: 1 847 3880349
Fax: 1 302 6555049
Website: https://www.monopartx.com/
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Monopar Therapeutics Hits New 52-Week High at $68.18
Sep 18 2025 01:23 PM IST
share
Share Via
Monopar Therapeutics Hits New 52-Week High of $54.54
Sep 16 2025 11:30 AM IST
share
Share Via
How big is Monopar Therapeutics, Inc.?
Jun 22 2025 06:08 PM IST
share
Share Via